Novel Fibroblast Activation Protein Inhibitor-Based targeted Theranostics for Radioiodine Refractory differentiated Thyroid Cancer Patients: A Pilot Study.

Sanjana Ballal,Madhav Prasad Yadav,Euy Sung Moon,Frank Roesch,Samta Kumari,Shipra Agarwal,Madhavi Tripathi,Ranjit Kumar Sahoo,Bharadwaj Srinivas Mangu,Avinash Tupalli,Chandrasekhar Bal

Novel Fibroblast Activation Protein Inhibitor-Based targeted Theranostics for Radioiodine Refractory differentiated Thyroid Cancer Patients: A Pilot Study.

2021

Sanjana Ballal
Madhav Prasad Yadav
Euy Sung Moon
Frank Roesch
Samta Kumari
Shipra Agarwal
Madhavi Tripathi
Ranjit Kumar Sahoo
Bharadwaj Srinivas Mangu
Avinash Tupalli
Chandrasekhar Bal

Background: This exploratory study was to assess clinical and safety data with a novel fibroblast activation protein inhibitor-based targeted theranostics as a salvage treatment option in radioiodi...

Keywords:

Fibroblast activation protein, alpha
Refractory
Cancer research
salvage treatment
Medicine
Thyroid cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations